CONEXEU SCIENCES INC.

Profile

Company Names

CONEXEU SCIENCES INC.

Addresses

50 WEST LIBERTY STREET, SUITE 880, RENO, NV 89501

Phone Numbers

604-315-4722

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2022

State Incorporated:

NEVADA

Total Amount Raised:

$7,237,610.00

Number of Funding Rounds:

13
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
13
2026-06-22 
$86,320.00 
$86,320.00 
$0.00 
Equity 
12
2026-06-18 
$203.00 
$465,953.00 
$465,750.00 
 
11
2026-05-28 
$22,905.00 
$137,427.00 
$114,522.00 
Equity 
10
2026-05-14 
$44,700.00 
$44,700.00 
$0.00 
Equity 
9
2026-05-12 
$543.00 
$1,248,634.00 
$1,248,091.00 
 
8
2026-03-25 
$1,815,000.00 
$1,815,000.00 
$0.00 
Equity 
7
2026-03-16 
$44,698.00 
$44,698.00 
$0.00 
Equity 
6
2026-02-11 
$467.00 
$1,072,437.00 
$1,071,970.00 
 
5
2026-01-26 
$810,000.00 
$810,000.00 
$0.00 
Equity 
4
2025-11-14 
$202,299.00 
$202,299.00 
$0.00 
Equity 
3
2025-10-28 
$2,921,446.00 
$2,921,446.00 
$0.00 
Equity 
2
2025-06-05 
$1,700.00 
$2,200.00 
$500.00 
Equity 
1
2025-04-10 
$1,287,329.00 
$2,531,964.00 
$1,244,635.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANA 
 
BASTIANI-POSNER 
DIRECTOR
CONEXEU SCIENCES INC.
DAVID 
R 
BOGART 
DIRECTOR, EXECUTIVE OFFICER
CONEXEU SCIENCES INC.
APRIL 
 
BURKE 
DIRECTOR
CONEXEU SCIENCES INC.
CLAUDIA 
 
CHAVEZ-MUNOZ 
EXECUTIVE OFFICER
CONEXEU SCIENCES INC.
ANDREW 
 
COSTA 
DIRECTOR
CONEXEU SCIENCES INC.
AARON 
 
FARBERG 
DIRECTOR
CONEXEU SCIENCES INC.
MILES 
 
HARRISON 
EXECUTIVE OFFICER, DIRECTOR
CONEXEU SCIENCES INC.
STEPHEN 
D 
INOUYE 
EXECUTIVE OFFICER
CONEXEU SCIENCES INC.
Z 
PAUL 
LORENC 
DIRECTOR
CONEXEU SCIENCES INC.
BRIAN 
 
PILCHER 
EXECUTIVE OFFICER, DIRECTOR
SUNEVA MEDICAL INC.   |  SUNEVA MEDICAL, INC.   |  CONEXEU SCIENCES INC.
SEBASTIAN 
 
PURCELL 
DIRECTOR
CONEXEU SCIENCES INC.
JEFF 
 
SHARPE 
EXECUTIVE OFFICER, DIRECTOR
CONEXEU SCIENCES INC.
CLAUDIA 
 
STEPHEN 
EXECUTIVE OFFICER
CONEXEU SCIENCES INC.
MICHAEL 
 
WRIGHT 
EXECUTIVE OFFICER, DIRECTOR
HEALTHCARE PARTNERS INVESTMENTS LLC   |  EVERSPRING INC.   |  PREVENT BIOMETRICS, INC.   |  NUGEN MEDICAL DEVICES INC.   |  CONEXEU SCIENCES INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-06-30
D
Link
BIOTECHNOLOGY 
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842] 
DECLINE TO DISCLOSE 
 
2026-06-18 
2026-06-30
D
Link
BIOTECHNOLOGY 
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842] 
DECLINE TO DISCLOSE 
Equity 
2026-06-22 
2026-06-12
D/A
Link
BIOTECHNOLOGY 
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842] 
DECLINE TO DISCLOSE 
Equity 
2025-06-05 
2026-06-10
D
Link
BIOTECHNOLOGY 
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842] 
DECLINE TO DISCLOSE 
Equity 
2026-05-28 
2026-05-21
D
Link
BIOTECHNOLOGY 
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842] 
DECLINE TO DISCLOSE 
 
2026-05-12 
2026-05-21
D
Link
BIOTECHNOLOGY 
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842] 
DECLINE TO DISCLOSE 
Equity 
2026-05-14 
2026-04-01
D
Link
BIOTECHNOLOGY 
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842] 
DECLINE TO DISCLOSE 
Equity 
2026-03-25 
2026-03-23
D
Link
BIOTECHNOLOGY 
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842] 
DECLINE TO DISCLOSE 
Equity 
2026-03-16 
2026-02-27
D
Link
BIOTECHNOLOGY 
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842] 
DECLINE TO DISCLOSE 
 
2026-02-11 
2026-02-04
D
Link
BIOTECHNOLOGY 
ORTHOPEDIC, PROSTHETIC + SURGICAL APPLIANCES + SUPPLIES [3842] 
DECLINE TO DISCLOSE 
Equity 
2026-01-26 
2025-11-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-11-14 
2025-11-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-28 
2025-07-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-10 
2025-06-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-06-05 
2025-05-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#